Clinical trial
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
NCT00014248 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00014248 |
|---|---|
| Title | Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study And Pharmacokinetics Of Adenosine 5'- Triphosphate (ATP) When Administered By Intravenous Infusion On A Multiple Weekly Dose Schedule To Patients With Advanced Malignancies (Solid Tumors) |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cachexia, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | adenosine triphosphate, quality-of-life assessment |
| Start date | Oct 1, 2000 |
| Primary completion | Nov 1, 2002 |
| First posted | Jul 30, 2003 |
| Last update posted | Mar 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: